{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:57:33Z","timestamp":1790269053905,"version":"4.1.0"},"reference-count":207,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"am","delay-in-days":314,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bbcan.2023.188950","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T16:51:39Z","timestamp":1688575899000},"page":"188950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Lymphatic vasculature in ovarian cancer"],"prefix":"10.1016","volume":"1878","author":[{"given":"Sarit","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sramana","family":"Bhowmick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Sierra-Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmita","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Favour","family":"Afolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debarshi","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bbcan.2023.188950_bb0005","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1177\/1535370217697385","article-title":"Lymphangiogenesis: fuel, smoke, or extinguisher of inflammation\u2019s fire?","volume":"242","author":"Abouelkheir","year":"2017","journal-title":"Exp. Biol. Med. (Maywood, N.J.)"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1067\/mai.2003.1585","article-title":"Histamine in the immune regulation of allergic inflammation","volume":"112","author":"Akdis","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0015","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjc.6604216","article-title":"Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers","volume":"98","author":"Alam","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"42","key":"10.1016\/j.bbcan.2023.188950_bb0020","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1038\/onc.2011.602","article-title":"Interaction of tumor cells and lymphatic vessels in cancer progression","volume":"31","author":"Alitalo","year":"2012","journal-title":"Oncogene"},{"issue":"7070","key":"10.1016\/j.bbcan.2023.188950_bb0025","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04480","article-title":"Lymphangiogenesis in development and human disease","volume":"438","author":"Alitalo","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0030","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3892\/ol.2022.13396","article-title":"MicroRNA-126 expression in the peripheral white blood cells of patients with breast and ovarian cancer is a potential biomarker for the early prediction of cancer risk in the carriers of methylated BRCA1","volume":"24","author":"Al-Showimi","year":"2022","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/gyno.2001.6287","article-title":"Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinum-treated patients","volume":"82","author":"Alvarez","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"6353","key":"10.1016\/j.bbcan.2023.188950_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal2379","article-title":"Organotypic vasculature: from descriptive heterogeneity to functional pathophysiology","volume":"357","author":"Augustin","year":"2017","journal-title":"Science"},{"issue":"58","key":"10.1016\/j.bbcan.2023.188950_bb0045","doi-asserted-by":"crossref","first-page":"97851","DOI":"10.18632\/oncotarget.18415","article-title":"Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients","volume":"8","author":"Avril","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bbcan.2023.188950_bb0050","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdl499","article-title":"Pattern and prognostic factors in patients with malignant ascites: a retrospective study","volume":"18","author":"Ayantunde","year":"2007","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2023.188950_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071930","article-title":"Recent progress in gene therapy for ovarian cancer","volume":"19","author":"\u00c1yen","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0060","doi-asserted-by":"crossref","first-page":"20180114","DOI":"10.1515\/pp-2018-0114","volume":"3","author":"Bakrin","year":"2018","journal-title":"Pleura Peritoneum"},{"issue":"22","key":"10.1016\/j.bbcan.2023.188950_bb0065","article-title":"Expanded renal lymphatics improve recovery following kidney injury","volume":"9","author":"Baranwal","year":"2021","journal-title":"Phys. Rep."},{"issue":"9","key":"10.1016\/j.bbcan.2023.188950_bb0070","first-page":"1579","article-title":"Angiogenic protein expression in advanced epithelial ovarian cancer","volume":"3","author":"Barton","year":"1997","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0075","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.celrep.2014.08.056","article-title":"Fatty acid uptake and lipid storage induced by HIF-1\u03b1 contribute to cell growth and survival after hypoxia-reoxygenation","volume":"9","author":"Bensaad","year":"2014","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.bbcan.2023.188950_bb0080","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1158\/1078-0432.CCR-18-2277","article-title":"Phase IB dose escalation and expansion study of AKT inhibitor afuresertib with carboplatin and paclitaxel in recurrent platinum-resistant ovarian cancer","volume":"25","author":"Blagden","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/ijgc-2020-002207","article-title":"Role of cardiophrenic lymph node removal in advanced ovarian cancer","volume":"31","author":"Boria","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2023.188950_bb0090","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Brett","year":"2017","journal-title":"Cancer B. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/humupd\/dmt049","article-title":"Blood and lymphatic vasculature in the ovary: development, function and disease","volume":"20","author":"Brown","year":"2014","journal-title":"Hum. Reprod. Update"},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jcmgh.2020.09.007","article-title":"Oxidized low-density lipoprotein drives dysfunction of the liver lymphatic system","volume":"11","author":"Burchill","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0110","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ygyno.2010.11.035","article-title":"Overview of anti-angiogenic agents in development for ovarian cancer","volume":"121","author":"Burger","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ccr.2004.08.034","article-title":"PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis","volume":"6","author":"Cao","year":"2004","journal-title":"Cancer Cell"},{"issue":"39","key":"10.1016\/j.bbcan.2023.188950_bb0120","doi-asserted-by":"crossref","first-page":"15894","DOI":"10.1073\/pnas.1208324109","article-title":"Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis","volume":"109","author":"Cao","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0125","doi-asserted-by":"crossref","first-page":"18944","DOI":"10.1038\/s41598-019-55418-x","article-title":"FABP5 coordinates lipid signaling that promotes prostate cancer metastasis","volume":"9","author":"Carbonetti","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ijc.32749","article-title":"Cancer mortality predictions for 2019 in Latin America","volume":"147","author":"Carioli","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2023.188950_bb0135","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jhep.2021.07.016","article-title":"Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma","volume":"75","author":"Carpino","year":"2021","journal-title":"J. Hepatol."},{"issue":"32","key":"10.1016\/j.bbcan.2023.188950_bb0140","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1073\/pnas.0404272101","article-title":"Dose-dependent response of FGF-2 for lymphangiogenesis","volume":"101","author":"Chang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bbcan.2023.188950_bb0145","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/biolre\/iox134","article-title":"The function of high-density lipoprotein and low-density lipoprotein in the maintenance of mouse ovarian steroid balance","volume":"97","author":"Chang","year":"2017","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.bbcan.2023.188950_bb0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canep.2017.12.003","article-title":"Epithelial ovarian cancer mortality among Hispanic women: sub-ethnic disparities and survival trend across time: an analysis of SEER 1992-2013","volume":"52","author":"Chen","year":"2018","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.bbcan.2023.188950_bb0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s42003-019-0508-1","article-title":"Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells","volume":"2","author":"Chen","year":"2019","journal-title":"Commun. Biol."},{"issue":"10 Suppl","key":"10.1016\/j.bbcan.2023.188950_bb0160","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1002\/cncr.11345","article-title":"Pathology and classification of ovarian tumors","volume":"97","author":"Chen","year":"2003","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2023.188950_bb0165","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/ATVBAHA.116.308120","article-title":"MicroRNA-126a directs lymphangiogenesis through interacting with chemokine and Flt4 signaling in zebrafish","volume":"36","author":"Chen","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0170","article-title":"The pro-inflammatory cytokine TNF-\u03b1 inhibits lymphatic pumping via activation of the NF-\u03baB-iNOS signaling pathway","volume":"24","author":"Chen","year":"2017","journal-title":"Microcirculation (New York, N.Y.\u202f: 1994)"},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055309","article-title":"Serum vascular endothelial growth factor (VEGF-C) as a diagnostic and prognostic marker in patients with ovarian cancer","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bbcan.2023.188950_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042436","article-title":"TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells","volume":"7","author":"Cheng","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0185","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1172\/JCI87442","article-title":"Laminar flow downregulates notch activity to promote lymphatic sprouting","volume":"127","author":"Choi","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0190","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ygyno.2012.12.016","article-title":"Global ovarian cancer health disparities","volume":"129","author":"Chornokur","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3350\/cmh.2013.19.2.99","article-title":"The lymphatic vascular system in liver diseases: its role in ascites formation","volume":"19","author":"Chung","year":"2013","journal-title":"Clin. Mol. Hepatol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0200","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.21037\/gs-20-335","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer recurrence: systematic review and meta-analysis","volume":"9","author":"Cianci","year":"2020","journal-title":"Gland Surg."},{"issue":"11","key":"10.1016\/j.bbcan.2023.188950_bb0205","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/ijc.30676","article-title":"International patterns and trends in ovarian cancer incidence, overall and by histologic subtype","volume":"140","author":"Coburn","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ygyno.2011.03.036","article-title":"A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a gynecologic oncology group study","volume":"122","author":"Coleman","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0215","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2013.12.039","article-title":"Gynecologic cancer disparities: a report from the health disparities taskforce of the society of gynecologic oncology","volume":"133","author":"Collins","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"18","key":"10.1016\/j.bbcan.2023.188950_bb0220","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","article-title":"Interleukin-6 as a therapeutic target in human ovarian cancer","volume":"17","author":"Coward","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2023.188950_bb0225","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1535370220983235","article-title":"Emerging roles for lymphatics in acute kidney injury: beneficial or maleficent?","volume":"246","author":"Creed","year":"2021","journal-title":"Exp. Biol. Med. (Maywood, N.J.)"},{"issue":"5","key":"10.1016\/j.bbcan.2023.188950_bb0230","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1084\/jem.20092277","article-title":"Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes","volume":"208","author":"Cursiefen","year":"2011","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0235","article-title":"What is new on ovarian carcinoma: integrated morphologic and molecular analysis following the new 2020 World Health Organization Classification of female genital tumors","volume":"11","author":"de Leo","year":"2021","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0240","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ajpath.2013.12.030","article-title":"Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms","volume":"184","author":"Decio","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.bbcan.2023.188950_bb0245","article-title":"Lymphovascular invasion as a criterion for adjuvant chemotherapy for FIGO stage I-IIa clear cell carcinoma, mucinous, low grade serous and low grade endometrioid ovarian cancer","volume":"50","author":"Delvall\u00e9e","year":"2021","journal-title":"Gynecol. Obstet. Human Reprod."},{"issue":"10","key":"10.1016\/j.bbcan.2023.188950_bb0250","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41581-021-00438-y","article-title":"The lymphatics in kidney health and disease","volume":"17","author":"Donnan","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0255","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41467-021-21217-0","article-title":"LETR1 is a lymphatic endothelial-specific lncRNA governing cell proliferation and migration through KLF4 and SEMA3C","volume":"12","author":"Ducoli","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0260","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jso.26700","article-title":"Factors associated with the involvement of lymph nodes in low-grade serous ovarian cancer","volume":"125","author":"Durmu\u015f","year":"2022","journal-title":"J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0265","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2013.06.089","article-title":"Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors","volume":"437","author":"Erez","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0270","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000658-197203000-00014","article-title":"Anti-angiogenesis: new concept for therapy of solid tumors","volume":"175","author":"Folkman","year":"1972","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0275","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/s41467-018-03959-6","article-title":"Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program","volume":"9","author":"Frye","year":"2018","journal-title":"Nat. Commun."},{"issue":"Suppl. 1","key":"10.1016\/j.bbcan.2023.188950_bb0280","doi-asserted-by":"crossref","first-page":"i50","DOI":"10.1093\/annonc\/mdw086","article-title":"Clear-cell carcinoma of the ovary","volume":"27","author":"Fujiwara","year":"2016","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0285","doi-asserted-by":"crossref","first-page":"G217","DOI":"10.1152\/ajpgi.00321.2018","article-title":"Prolonged intake of desloratadine: mesenteric lymphatic vessel dysfunction and development of obesity\/metabolic syndrome","volume":"316","author":"Gasheva","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"14","key":"10.1016\/j.bbcan.2023.188950_bb0290","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137652","article-title":"S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress\u2013dependent VEGF-C signaling","volume":"5","author":"Geng","year":"2020","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0295","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1038\/s41467-018-04987-y","article-title":"FABP4 as a key determinant of metastatic potential of ovarian cancer","volume":"9","author":"Gharpure","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2023.188950_bb0300","doi-asserted-by":"crossref","first-page":"1021038","DOI":"10.3389\/fphys.2022.1021038","article-title":"Oxidized low density lipoprotein in the liver causes decreased permeability of liver lymphatic- but not liver sinusoidal-endothelial cells via VEGFR-3 regulation of VE-cadherin","volume":"13","author":"Goldberg","year":"2022","journal-title":"Front. Physiol."},{"issue":"16","key":"10.1016\/j.bbcan.2023.188950_bb0305","doi-asserted-by":"crossref","first-page":"22650","DOI":"10.18632\/oncotarget.7998","article-title":"Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer","volume":"7","author":"Gomez-Roman","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2023.188950_bb0310","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42881","article-title":"Yap1 promotes sprouting and proliferation of lymphatic progenitors downstream of Vegfc in the zebrafish trunk","volume":"8","author":"Grimm","year":"2019","journal-title":"ELife"},{"key":"10.1016\/j.bbcan.2023.188950_bb0315","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bpobgyn.2016.12.001","article-title":"Targeted therapies for ovarian cancer","volume":"41","author":"Grunewald","year":"2017","journal-title":"Best Pract. Res. Clinical Obstet. Gynaecol."},{"key":"10.1016\/j.bbcan.2023.188950_bb0320","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.humpath.2016.03.006","article-title":"TNF-\u03b1 expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?","volume":"54","author":"Gupta","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbcan.2023.188950_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01168","article-title":"Lymphatic migration of immune cells","volume":"10","author":"Hampton","year":"2019","journal-title":"Front. Immunol."},{"issue":"Suppl. 24","key":"10.1016\/j.bbcan.2023.188950_bb0330","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1002\/cncr.32514","article-title":"How to manage lymph nodes in ovarian cancer","volume":"125","author":"Harter","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2023.188950_bb0335","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2407-10-145","article-title":"Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls","volume":"10","author":"Heerma van Voss","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2023.188950_bb0340","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2407-6-144","article-title":"Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival","volume":"6","author":"Herath","year":"2006","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0345","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1477-7827-1-73","article-title":"Estrogen, progesterone and epithelial ovarian cancer","volume":"1","author":"Ho","year":"2003","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0350","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12885-016-2259-4","article-title":"TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1\/2\/AP-1\/VEGF-D pathway","volume":"16","author":"Hong","year":"2016","journal-title":"BMC Cancer"},{"issue":"Pt 3","key":"10.1016\/j.bbcan.2023.188950_bb0355","first-page":"457","article-title":"The vascular anatomy of the ovary and the relative contribution of the ovarian and uterine arteries to the blood supply of the ovary in the Guinea-pig","volume":"137","author":"Hossain","year":"1983","journal-title":"J. Anat."},{"issue":"6","key":"10.1016\/j.bbcan.2023.188950_bb0360","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1158\/1535-7163.MCT-15-0144","article-title":"Dll4 inhibition plus aflibercept markedly reduces ovarian tumor growth","volume":"15","author":"Huang","year":"2016","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.bbcan.2023.188950_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158839","article-title":"Interleukin-6 induces vascular endothelial growth factor-C expression via Src-FAK-STAT3 signaling in lymphatic endothelial cells","volume":"11","author":"Huang","year":"2016","journal-title":"PLoS One"},{"issue":"Pt 4","key":"10.1016\/j.bbcan.2023.188950_bb0370","first-page":"845","article-title":"FGF2-induced Ras-MAPK signalling maintains lymphatic endothelial cell identity by upregulating endothelial-cell-specific gene expression and suppressing TGF\u03b2 signalling through Smad2","volume":"127","author":"Ichise","year":"2014","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0375","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.bjc.6602961","article-title":"Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival","volume":"94","author":"Ino","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0380","doi-asserted-by":"crossref","first-page":"7650","DOI":"10.1038\/s41598-019-44095-5","article-title":"Essential role of prostaglandin E2 and the EP3 receptor in lymphatic vessel development during zebrafish embryogenesis","volume":"9","author":"Iwasaki","year":"2019","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.bbcan.2023.188950_bb0385","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1242\/dev.095026","article-title":"TGF\u03b2 signaling is required for sprouting lymphangiogenesis during lymphatic network development in the skin","volume":"140","author":"James","year":"2013","journal-title":"Development (Cambridge, England)"},{"issue":"9","key":"10.1016\/j.bbcan.2023.188950_bb0390","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/jc.2016-3456","article-title":"Ovarian lipid metabolism modulates circulating lipids in premenopausal women","volume":"102","author":"Jensen","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2023.188950_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.593017","article-title":"Deregulation of lipid metabolism: the critical factors in ovarian cancer","volume":"10","author":"Ji","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0400","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ajpath.2015.09.016","article-title":"Inhibition of mast cell-derived histamine decreases human cholangiocarcinoma growth and differentiation via c-kit\/stem cell factor-dependent signaling","volume":"186","author":"Johnson","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0405","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0410","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1038\/s41598-021-88382-6","article-title":"Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality","volume":"11","author":"Jukonen","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0415","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1172\/JCI71606","article-title":"Mechanisms of lymphatic metastasis","volume":"124","author":"Karaman","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.bbcan.2023.188950_bb0420","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/ATVBAHA.117.309883","article-title":"Lymphangiogenesis facilitates initial lymph formation and enhances the dendritic cell mobilizing chemokine CCL21 without affecting migration","volume":"37","author":"Karlsen","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.bbcan.2023.188950_bb0425","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/labinvest.2011.84","article-title":"Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema","volume":"91","author":"Kashiwagi","year":"2011","journal-title":"Lab. Investig."},{"issue":"8","key":"10.1016\/j.bbcan.2023.188950_bb0430","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1158\/2326-6066.CIR-18-0337","article-title":"Tumor lymphatic function regulates tumor inflammatory and immunosuppressive microenvironments","volume":"7","author":"Kataru","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"6","key":"10.1016\/j.bbcan.2023.188950_bb0435","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/156652309790031148","article-title":"Addressing the challenge: current and future directions in ovarian cancer therapy","volume":"9","author":"Kaur","year":"2009","journal-title":"Curr. Gene Ther."},{"issue":"13","key":"10.1016\/j.bbcan.2023.188950_bb0440","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood-2009-12-256297","article-title":"Prox1 expression is negatively regulated by miR-181 in endothelial cells","volume":"116","author":"Kazenwadel","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2023.188950_bb0445","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1038\/srep15007","article-title":"Junb controls lymphatic vascular development in zebrafish via miR-182","volume":"5","author":"Kiesow","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0450","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1530\/REP-19-0501","article-title":"The ovarian stroma as a new frontier","volume":"160","author":"Kinnear","year":"2020","journal-title":"Reproduction"},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0455","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2023.188950_bb0460","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/IGC.0000000000000514","article-title":"Understanding lymphatic drainage pathways of the ovaries to predict sites for sentinel nodes in ovarian cancer","volume":"25","author":"Kleppe","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0465","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1530\/rep.1.01074","article-title":"TGF-beta superfamily members and ovarian follicle development","volume":"132","author":"Knight","year":"2006","journal-title":"Reproduction (Cambridge, England)"},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020416","article-title":"The evolution of ovarian carcinoma subclassification","volume":"14","author":"K\u00f6bel","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0475","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ydbio.2018.03.006","article-title":"Mir-126 is a conserved modulator of lymphatic development","volume":"437","author":"Kontarakis","year":"2018","journal-title":"Dev. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0480","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1677\/joe.0.1200363","article-title":"Histamine, mast cells and ovarian function","volume":"120","author":"Krishna","year":"1989","journal-title":"J. Endocrinol."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0485","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10456-019-09669-x","article-title":"Cancer stem cells contribute to angiogenesis and lymphangiogenesis in serous adenocarcinoma of the ovary","volume":"22","author":"Krishnapriya","year":"2019","journal-title":"Angiogenesis"},{"issue":"11","key":"10.1016\/j.bbcan.2023.188950_bb0490","first-page":"5200","article-title":"Collecting lymphatic vessel permeability facilitates adipose tissue inflammation and distribution of antigen to lymph node-homing adipose tissue dendritic cells","volume":"194","author":"Kuan","year":"2015","journal-title":"J. Immunol. (Baltimore, Md.\u202f: 1950)"},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0495","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1158\/0008-5472.CAN-06-2941","article-title":"The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells","volume":"67","author":"Kulbe","year":"2007","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.bbcan.2023.188950_bb0500","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","article-title":"Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis","volume":"37","author":"Ladanyi","year":"2018","journal-title":"Oncogene"},{"issue":"2\u20133","key":"10.1016\/j.bbcan.2023.188950_bb0510","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10555-018-9734-0","article-title":"Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer","volume":"37","author":"Lala","year":"2018","journal-title":"Cancer Metastasis Rev."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0515","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/ijgc-2019-000981","article-title":"Recurrence patterns in patients with abnormal cardiophrenic lymph nodes at ovarian cancer diagnosis","volume":"30","author":"Larish","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059083","article-title":"Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K\/Akt\/mTOR and MAPK\/ERK signaling in ovarian cancer cells","volume":"8","author":"Lau","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0525","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2018.10.031","article-title":"Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic oncology group study (KGOG 3041)","volume":"152","author":"Lee","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0530","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.bbcan.2023.188950_bb0535","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00404-014-3377-3","article-title":"PI3K\/AKT\/mTOR signaling pathway as a therapeutic target for ovarian cancer","volume":"290","author":"Li","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"issue":"46","key":"10.1016\/j.bbcan.2023.188950_bb0540","doi-asserted-by":"crossref","first-page":"18784","DOI":"10.1073\/pnas.1116152108","article-title":"Impaired lymphatic contraction associated with immunosuppression","volume":"108","author":"Liao","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.bbcan.2023.188950_bb0545","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/ATVBAHA.110.210633","article-title":"Notch leads lymphatics and links them to blood vessels","volume":"30","author":"Liao","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2014.04.003","article-title":"VEGFR3 inhibition chemosensitizes ovarian cancer stemlike cells through down-regulation of BRCA1 and BRCA2","volume":"16","author":"Lim","year":"2014","journal-title":"Neoplasia (New York, N.Y.)"},{"key":"10.1016\/j.bbcan.2023.188950_bb0555","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.560170","article-title":"Angiotensin II stimulates the proliferation and migration of lymphatic endothelial cells through angiotensin type 1 receptors","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040952","article-title":"High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2023.188950_bb0565","article-title":"Lipid metabolic process involved in oocyte maturation during folliculogenesis","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0570","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/path.4000","article-title":"MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma","volume":"228","author":"Liu","year":"2012","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.10.1104","article-title":"Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California","volume":"212","author":"Long","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0580","article-title":"Lymphovascular space invasion and estrogen receptor status in high-grade serous ovarian cancer - A multicenter study by the FRANCOGYN group","volume":"51","author":"Lorenzini","year":"2022","journal-title":"Gynecol. Obstet. Human Reprod."},{"issue":"7560","key":"10.1016\/j.bbcan.2023.188950_bb0585","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0590","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2013.03.026","article-title":"An international assessment of ovarian cancer incidence and mortality","volume":"130","author":"Lowe","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0595","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.21037\/tcr.2020.02.42","article-title":"Bevacizumab combined with chemotherapy in platinum-resistant ovarian cancer: beyond the AURELIA trial","volume":"9","author":"Lyon","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0600","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s12893-021-01368-z","article-title":"Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique","volume":"21","author":"Macci\u00f2","year":"2021","journal-title":"BMC Surg."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0605","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1101\/gad.330105","article-title":"PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature","volume":"19","author":"M\u00e4kinen","year":"2005","journal-title":"Genes Dev."},{"issue":"11","key":"10.1016\/j.bbcan.2023.188950_bb0610","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1002\/ijc.32653","article-title":"Identification of novel epithelial ovarian cancer loci in women of African ancestry","volume":"146","author":"Manichaikul","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2023.188950_bb0615","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1161\/ATVBAHA.117.309123","article-title":"Scavenger receptor CD36 directs nonclassical monocyte patrolling along the endothelium during early atherogenesis","volume":"37","author":"Marcovecchio","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0620","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tcm.2014.12.004","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy (ARVD\/C): we\u2019ve come a long way, baby","volume":"25","author":"Marcus","year":"2015","journal-title":"Trends Cardiovasculc. Med."},{"issue":"12","key":"10.1016\/j.bbcan.2023.188950_bb0625","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.4161\/cbt.6.12.4976","article-title":"PDGF BB induces VEGF secretion in ovarian cancer","volume":"6","author":"Matei","year":"2007","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0630","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pathol.2017.10.006","article-title":"Endometriosis-associated ovarian neoplasia","volume":"50","author":"Matias-Guiu","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.bbcan.2023.188950_bb0635","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0640","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ijc.24406","article-title":"Prediagnostic circulating follicle stimulating hormone concentrations and ovarian cancer risk","volume":"125","author":"McSorley","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0645","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0002-9440(10)65669-6","article-title":"Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization","volume":"153","author":"Mesiano","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.bbcan.2023.188950_bb0650","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1073\/pnas.1512304113","article-title":"In vivo imaging reveals an essential role of vasoconstriction in rupture of the ovarian follicle at ovulation","volume":"113","author":"Migone","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2023.188950_bb0655","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1038\/ncomms7725","article-title":"RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock","volume":"6","author":"Mikelis","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2023.188950_bb0660","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcdb.2015.02.010","article-title":"Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes","volume":"40","author":"Minciacchi","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0665","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2013.3","article-title":"Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET","volume":"2","author":"Mitamura","year":"2013","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbcan.2023.188950_bb0670","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int. J. Women\u2019s Health"},{"issue":"6","key":"10.1016\/j.bbcan.2023.188950_bb0675","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/ATVBAHA.118.310997","article-title":"Lymphatic vasculature requires estrogen receptor-\u03b1 signaling to protect from lymphedema","volume":"38","author":"Morfoisse","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"18","key":"10.1016\/j.bbcan.2023.188950_bb0680","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/onc.2015.302","article-title":"Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis","volume":"35","author":"Nagaraja","year":"2016","journal-title":"Oncogene"},{"issue":"6346","key":"10.1016\/j.bbcan.2023.188950_bb0685","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.aai8515","article-title":"Origins of lymphatic and distant metastases in human colorectal cancer","volume":"357","author":"Naxerova","year":"2017","journal-title":"Science (New York, N.Y.)"},{"issue":"5","key":"10.1016\/j.bbcan.2023.188950_bb0690","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1172\/JCI116446","article-title":"Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression","volume":"91","author":"Naylor","year":"1993","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0695","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.bbcan.2023.188950_bb0700","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.stem.2022.05.007","article-title":"Lymphatics act as a signaling hub to regulate intestinal stem cell activity","volume":"29","author":"Niec","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.bbcan.2023.188950_bb0705","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"issue":"23","key":"10.1016\/j.bbcan.2023.188950_bb0710","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1158\/0008-5472.CAN-05-0623","article-title":"Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine","volume":"65","author":"Nilsson","year":"2005","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0715","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","article-title":"Angiogenesis in cancer","volume":"2","author":"Nishida","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0720","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cell.2020.06.039","article-title":"The lymphatic vasculature in the 21st century: novel functional roles in homeostasis and disease","volume":"182","author":"Oliver","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0725","first-page":"64","article-title":"Fine structure and morphometric analysis of lymphatic capillaries in the developing corpus luteum of the rabbit","volume":"20","author":"Otsuki","year":"1987","journal-title":"Lymphology"},{"issue":"7","key":"10.1016\/j.bbcan.2023.188950_bb0730","doi-asserted-by":"crossref","DOI":"10.1242\/bio.059191","article-title":"Nuclear localization of histamine receptor 2 in primary human lymphatic endothelial cells","volume":"11","author":"Pal","year":"2022","journal-title":"Biol. Open"},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0735","doi-asserted-by":"crossref","first-page":"R590","DOI":"10.1152\/ajpregu.00255.2019","article-title":"Histamine-mediated autocrine signaling in mesenteric perilymphatic mast cells","volume":"318","author":"Pal","year":"2020","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"5","key":"10.1016\/j.bbcan.2023.188950_bb0740","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18050965","article-title":"Aged lymphatic vessels and mast cells in Perilymphatic tissues","volume":"18","author":"Pal","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2023.188950_bb0745","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3389\/fimmu.2020.01234","article-title":"Emerging roles of mast cells in the regulation of lymphatic Immuno-physiology","volume":"11","author":"Pal","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2023.188950_bb0750","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/ncomms3977","article-title":"microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition","volume":"5","author":"Parikh","year":"2014","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.bbcan.2023.188950_bb0755","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1128\/MCB.00185-10","article-title":"miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo","volume":"30","author":"Pedrioli","year":"2010","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0760","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/ije\/dyx252","article-title":"Racial\/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies","volume":"47","author":"Peres","year":"2018","journal-title":"Int. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.bbcan.2023.188950_bb0765","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood-2012-08-450502","article-title":"Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1","volume":"121","author":"Platonova","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0770","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","article-title":"Hematogenous metastasis of ovarian cancer: rethinking mode of spread","volume":"26","author":"Pradeep","year":"2014","journal-title":"Cancer Cell"},{"issue":"13","key":"10.1016\/j.bbcan.2023.188950_bb0775","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1200\/JCO.2013.51.4489","article-title":"Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial","volume":"32","author":"Pujade-Lauraine","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0780","first-page":"166","article-title":"Morphologic, Immunophenotypic, and molecular features of epithelial ovarian cancer","volume":"30","author":"Ramalingam","year":"2016","journal-title":"Oncology (Williston Park, N.Y.)"},{"key":"10.1016\/j.bbcan.2023.188950_bb0785","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1476-4598-5-62","article-title":"Ovarian epithelial cancer: a role for PGE2-synthesis and signalling in malignant transformation and progression","volume":"5","author":"Rask","year":"2006","journal-title":"Mol. Cancer"},{"issue":"25","key":"10.1016\/j.bbcan.2023.188950_bb0790","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus bevacizumab as first-line maintenance in ovarian cancer","volume":"381","author":"Ray-Coquard","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0795","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"10","author":"Riggs","year":"2020","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0800","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1096\/fj.14-261636","article-title":"Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer","volume":"29","author":"Russell","year":"2015","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0805","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/PAS.0b013e318141fc7a","article-title":"Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion","volume":"32","author":"Sangoi","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0810","first-page":"177","article-title":"Secretion of vascular endothelial growth factor in ovarian cancer","volume":"20","author":"Santin","year":"1999","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"24","key":"10.1016\/j.bbcan.2023.188950_bb0815","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1158\/0008-5472.CAN-09-1213","article-title":"Gonadotropin-regulated lymphangiogenesis in ovarian cancer is mediated by LEDGF-induced expression of VEGF-C","volume":"69","author":"Sapoznik","year":"2009","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0820","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.maturitas.2013.11.009","article-title":"New perspectives in ovarian cancer treatment","volume":"77","author":"Schmid","year":"2014","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0825","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10585-012-9541-x","article-title":"Tumor location and nature of lymphatic vessels are key determinants of cancer metastasis","volume":"30","author":"Shayan","year":"2013","journal-title":"Clin. Exp. Metastasis"},{"issue":"6","key":"10.1016\/j.bbcan.2023.188950_bb0830","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.3892\/or.2015.3916","article-title":"Interleukin-8: A potent promoter of human lymphatic endothelial cell growth in gastric cancer","volume":"33","author":"Shi","year":"2015","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.bbcan.2023.188950_bb0835","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0840","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/path.2935","article-title":"Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma","volume":"225","author":"Shinriki","year":"2011","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0845","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2023.188950_bb0850","doi-asserted-by":"crossref","unstructured":"Siegel, R. L., Miller, K. D., & Jemal, A. (n.d.). Cancer statistics, 2016. CA Cancer J. Clin., 66(1), 7\u201330. doi:https:\/\/doi.org\/10.3322\/caac.21332.","DOI":"10.3322\/caac.21332"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0855","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0860","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13048-017-0320-9","article-title":"Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies","volume":"10","author":"Sipak-Szmigiel","year":"2017","journal-title":"J. Ovarian Res."},{"issue":"12","key":"10.1016\/j.bbcan.2023.188950_bb0865","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/ijc.24702","article-title":"Tumor metastasis and the lymphatic vasculature","volume":"125","author":"Sleeman","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb0870","first-page":"115","article-title":"Local adjustment of blood and lymph circulation in the hormonal regulation of reproduction in female pigs--facts, conclusions and suggestions for future research","volume":"2","author":"Stefa\u0144czyk-Krzymowska","year":"2002","journal-title":"Reprod. Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2023.188950_bb0875","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/sj.bjc.6603144","article-title":"Role of lymphangiogenesis in epithelial ovarian cancer","volume":"94","author":"Sundar","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2023.188950_bb0880","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2023.188950_bb0885","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1038\/jid.2013.152","article-title":"Lymphatic endothelium forms integrin-engaging 3D structures during DC transit across inflamed lymphatic vessels","volume":"133","author":"Teijeira","year":"2013","journal-title":"J. Investig. Dermatol."},{"issue":"8","key":"10.1016\/j.bbcan.2023.188950_bb0890","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/sj.bjc.6603993","article-title":"Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells","volume":"97","author":"Timoshenko","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"1A","key":"10.1016\/j.bbcan.2023.188950_bb0895","first-page":"A68","article-title":"The cancer genome atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp. Oncol. (Poznan, Poland)"},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0900","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"2 Pt 2","key":"10.1016\/j.bbcan.2023.188950_bb0905","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/hy02t2.102909","article-title":"Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats","volume":"39","author":"Touyz","year":"2002","journal-title":"Hypertension (Dallas, Tex.\u202f: 1979)"},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0910","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/10799893.2013.876042","article-title":"Diverse effects of LPA receptors on cell motile activities of cancer cells","volume":"34","author":"Tsujiuchi","year":"2014","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.bbcan.2023.188950_bb0915","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12943-015-0306-4","article-title":"The role of CCL21\/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis","volume":"14","author":"Tutunea-Fatan","year":"2015","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0920","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ccr.2004.09.024","article-title":"Vascular frontiers without borders: multifaceted roles of platelet-derived growth factor (PDGF) in supporting postnatal angiogenesis and lymphangiogenesis","volume":"6","author":"Vincent","year":"2004","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0925","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/GCO.0000000000000592","article-title":"Latest clinical evidence of maintenance therapy in ovarian cancer","volume":"32","author":"Walsh","year":"2020","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0930","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ygyno.2006.10.016","article-title":"The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms","volume":"104","author":"Wang","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0935","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41392-020-0199-6","article-title":"Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct Target Ther."},{"issue":"12","key":"10.1016\/j.bbcan.2023.188950_bb0940","first-page":"3367","article-title":"Platelet-derived growth factor-D promotes ovarian cancer invasion by regulating matrix metalloproteinases 2 and 9","volume":"12","author":"Wang","year":"2011","journal-title":"Asian Pacific J. Cancer Prevent."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0945","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2012.04.013","article-title":"Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion","volume":"59","author":"Wang","year":"2012","journal-title":"Cytokine"},{"issue":"7639","key":"10.1016\/j.bbcan.2023.188950_bb0950","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature21028","article-title":"The role of fatty acid \u03b2-oxidation in lymphangiogenesis","volume":"542","author":"Wong","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0955","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/lrb.2009.0009","article-title":"Existence of the lymphatic system in the primate corpus luteum","volume":"7","author":"Xu","year":"2009","journal-title":"Lymphat. Res. Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2023.188950_bb0960","doi-asserted-by":"crossref","first-page":"10459","DOI":"10.1074\/jbc.M311891200","article-title":"TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor","volume":"279","author":"Xu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2023.188950_bb0965","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.743073","article-title":"Update on poly ADP-ribose polymerase inhibitors in ovarian cancer with non-BRCA mutations","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbcan.2023.188950_bb0970","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb0975","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrc2583","article-title":"Beyond chemotherapy: targeted therapies in ovarian cancer","volume":"9","author":"Yap","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb0980","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1186\/s40064-016-2390-3","article-title":"The effect of the immune system on ovarian function and features of ovarian germline stem cells","volume":"5","author":"Ye","year":"2016","journal-title":"SpringerPlus"},{"issue":"4","key":"10.1016\/j.bbcan.2023.188950_bb0985","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3892\/ijo.2013.1819","article-title":"Bioinformatic analysis of chemokine (C-C motif) ligand 21 and SPARC-like protein 1 revealing their associations with drug resistance in ovarian cancer","volume":"42","author":"Yin","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2023.188950_bb0990","unstructured":"Yukita, A., Asano, M., Okamoto, T., Mizutani, S., & Suzuki, H. (n.d.). Suppression of ascites formation and re-accumulation associated with human ovarian cancer by an anti-VPF monoclonal antibody in vivo. Anticancer Res., 20(1A), 155\u2013160."},{"key":"10.1016\/j.bbcan.2023.188950_bb0995","article-title":"Lymphatic endothelial cell junctions: molecular regulation in physiology and diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb1000","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2023.188950_bb1005","article-title":"Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer","volume":"1875","author":"Zhang","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb1010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13046-019-1127-x","article-title":"Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2023.188950_bb1015","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1186\/s12885-019-6139-6","article-title":"Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2023.188950_bb1020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121870","article-title":"Ovarian cancer-why lipids matter","volume":"11","author":"Zhao","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bbcan.2023.188950_bb1025","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1172\/JCI71603","article-title":"Lymphangiogenic factors, mechanisms, and applications","volume":"124","author":"Zheng","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2023.188950_bb1030","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.619581","article-title":"Disease burden and attributable risk factors of ovarian cancer from 1990 to 2017: findings from the global burden of disease study 2017","volume":"9","author":"Zhou","year":"2021","journal-title":"Front. Public Health"},{"issue":"19","key":"10.1016\/j.bbcan.2023.188950_bb1035","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1158\/1078-0432.CCR-12-0708","article-title":"The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis","volume":"18","author":"Zhuo","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2023.188950_bib1036","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.biocel.2018.05.006","article-title":"MiR-128-3p directly targets VEGFC\/VEGFR3 to modulate the proliferation of lymphatic endothelial cells through Ca2+ signaling","volume":"102","author":"Zhou","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X23000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X23000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:49:35Z","timestamp":1759639775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X23000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":207,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0304419X23000999"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2023.188950","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphatic vasculature in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2023.188950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"188950"}}